Thanks oxxa23! Couple other things discussed/answered:
- onCarlytics with Bispecific T cell engagers (Blinatumomab) looking even more promising than onCarlytics with Car-Ts.
- Patients on the onCarlytics with Estrella Artemis don't require hospital stay, rather as outpatients.
- What drives him (CF33 inventor)? He responded - helping people.
- He wants CF33 to be a medicine not an investigational/experimental drug.
- How nervous are other BP companies? He responded - it is a competitive space. But there is excitement working together rather than against IMU.
- CF33 can be administered multiple times and not just limited to single dose.
- IMU has been helping COH team finding potential partners for collaboration.
Why IMU is a multi multi bagger, page-9641
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.002(4.35%) |
Mkt cap ! $357.0M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.9¢ | 4.6¢ | $977.7K | 20.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 3232340 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.8¢ | 854027 | 4 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |